// App-Quantinova.ai

e14113 : A new concept to target the proteasome: disrupting protein-protein interactions in the proteasome super-assembly as a way to stop the growth of cancer cells.

Researchers

Presenter

  • Maria E Gaczynska

Principal Investigators

  • Pawel A. Osmulski

  • Karolina Wlodyga

  • Tim Huang

Medical Centers

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bortezomib

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved